Researchers at Koç University have developed an open-access, machine learning–assisted tool that automates microfluidic chip design, lowering the ...
Johnson & Johnson today announced new real world head-to-head evidence demonstrating that patients with metastatic castration-sensitive prostate cancer (mCSPC) initiating ERLEADA® without docetaxel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results